Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-1-amino-3-18F-flurocyclobutane-1-carboxylic Acid (Axumin) Positron Emission Tomography/Computed Tomography Prior to Retroperitoneal Lymph Node Dissection for Testicular Cancer

NCT03426865 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT03426865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03426865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-1-amino-3-18F-flurocyclobutane-1-carboxylic Acid (Axumin) Positron Emission Tomography/Computed Tomography Prior to Retroperitoneal Lymph Node Dissection for Testicular Cancer
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
June 1, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

germ cell cancer metastatic, germ cell cancer, nos, germ cell neoplasm of retroperitoneum, germ cell tumor, germ cell tumor of testis, germ cell tumor, testicular, childhood, testicular cancer, testicular choriocarcinoma, testicular diseases, testicular germ cell tumor, testicular neoplasms, testicular yolk sac tumor, testis cancer